Trilogy Capital’s Nutrien NTR Stock Holding History

Trilogy Capital’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-880	Closed	-$51K	–	423
2018 Q3	$51K	Buy	880 +6	+0.7%	+$332	0.01%	194
2018 Q2	$48K	Buy	874 +6	+0.7%	+$298	0.01%	183
2018 Q1	$41K	Buy	+868	New	+$43.5K	0.01%	175

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Trilogy Capital's NTR Position: Q4 2018 in Review

Trilogy Capital sold out of Nutrien (NTR) in Q4 2018, closing a stake of 880 shares — an estimated $51K sold.

Trilogy Capital first reported a position in NTR in Q1 2018 and held it in 3 quarters. The position peaked at $51K in Q3 2018. 581 funds tracked by Wall St. Rank hold NTR as of Q4 2018.

Trilogy Capital reported no remaining Nutrien position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 880 Nutrien shares in Q4 2018, an estimated $51K.
Trilogy Capital first reported a position in Nutrien in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Nutrien position peaked at $51K in Q3 2018.
581 funds tracked by Wall St. Rank held Nutrien as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.